Pathogen inhibition
Anti inflammatory effect
Immune system modulation
Metabolic process improvement
Safety
Stability
Digestions & Dysbyosis
H. Pylori
Anti viral effect
Anti allergy
Children's health
Women's health
E.faecium L3 during antibiotic treatment
Gut-brain axis
 
Pathogen inhibition
Dynamics of contamination and persistence of Clostridium difficile in intestinal microbiota in newborn infants during antibiotic therapy and use of probiotic strain enterococcus faecium L3
Positive clinical outcomes derived from using a proprietary mixture of selected strains during pregnancy
Gut Microbiota, Probiotics, and Human Health
In vivo Testing of Functional Properties of Three Selected Probiotic Strains.
Enterococcus as probiotics- what is the advantage?
Probiotics at War Against Viruses -What Is Missing From the Picture?
Enterococcus faecium L-3 in Eradication of Helicobacter pylori- In-vivo and In-vitro
The need for individual selection of probiotics containing lactobacilli and enterococci to improve efficacy therapy for campylobacteriosis
Anti inflammatory effect
The protective effect of Enterococcus faecium L-3 in experimental allergic encephalomyelitis in rats is dose-dependent
Influence of probiotics on cytokine production in the in vitro and in vivo systems
Irritable bowel syndrome therapy in Vietnam
Immune system modulation
The influence of probiotic Enterococcus faecium strain l5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics
In vivo Testing of Functional Properties of Three Selected Probiotic Strains.
The protective effect of Enterococcus faecium L-3 in experimental allergic encephalomyelitis in rats is dose-dependent
The need for individual selection of probiotics containing lactobacilli and enterococci to improve efficacy therapy for campylobacteriosis
Influence of probiotics on cytokine production in the in vitro and in vivo systems
Modern probiotic functional products in the practice of training athletes
Metabolic process improvement
Modern probiotic functional products in the practice of training athletes
Trophological status and quality of life in infants administered probiotic enterococci
The protective effect of Enterococcus faecium L-3 in experimental allergic encephalomyelitis in rats is dose-dependent
Glucose absorption and digestive enzyme activities in the type 2 diabetic rats after administration of metformin and probiotic strain of Enterococcus faecium L3
Safety
Enterococcus as probiotics- what is the advantage?
Stability
Study of adaptation properties of the studied microorganisms
Modern probiotic functional products in the practice of training athletes
Digestion & Dysbiosis
The influence of probiotic Enterococcus faecium strain l5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics
Gut Microbiota, Probiotics, and Human Health
Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication.pdf
Irritable bowel syndrome therapy in Vietnam
H. Pylori
Enterococcus faecium L-3 in Eradication of Helicobacter pylori- In-vivo and In-vitro
Gut Microbiota, Probiotics, and Human Health
Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication.pdf
Anti viral effect
Probiotics at War Against Viruses -What Is Missing From the Picture?
AntiInfluenza Activity Of Enterococcus faecium L3
Anti allergy
Terapia batterica razionale ed evidenze in ambito allergologico
Treatment with a Probiotic Mixture Containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the Prevention of Allergic Rhinitis Symptoms in Children
Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB12 and Enterococcus faecium L3 in atopic children
Children’s health
Dynamics of contamination and persistence of Clostridium difficile in intestinal microbiota in newborn infants during antibiotic therapy and use of probiotic strain enterococcus faecium L3
Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB12 and Enterococcus faecium L3 in atopic children
Treatment with a Probiotic Mixture Containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the Prevention of Allergic Rhinitis Symptoms in Children
Use of a probiotic mixture containing Bifidobacterium animalis subsp. lactis BB-12 and Enterococcus faecium L3 as prophylaxis to reduce the incidence of acute gastroenteritis and upper respiratory tract infections in children
Trophological status and quality of life in infants administered probiotic enterococci
Women’s health
Positive clinical outcomes derived from using a proprietary mixture of selected strains during pregnancy
E.faecium L3 during antibiotic treatment
The influence of probiotic Enterococcus faecium strain l5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics
Impact of a two-bacterial-strain formula, containing Bifidobacterium animalis lactis BB-12 and Enterococcus faecium L3, administered before and after therapy for Helicobacter pylori eradication
Dynamics of contamination and persistence of Clostridium difficile in intestinal microbiota in newborn infants during antibiotic therapy and use of probiotic strain enterococcus faecium L3
Gut-brain axis
The protective effect of Enterococcus faecium L-3 in experimental allergic encephalomyelitis in rats is dose-dependent